Sunday, October 07, 2018 3:24:47 PM
We all know that the FDA innovation challenge has nothing to do with BIEL being cleared for Actipatch and RecoveryRx. Those are two separate tracks, but based on the CEO radio interview, he elected to wait for the challenge and have RecoveryRx part of it to facilitate and expedite RecoveryRX clearance with the help and exposure of the FDA through the challenge. I invite you to read the radio interview before the last one on record.
Every time you enter a context and you are selected and others rejected, you win, and this will be a HUGE WIN for BIEL, if selected by the FDA in November.
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM